Literature DB >> 25575866

Development of porous PLGA/PEI1.8k biodegradable microspheres for the delivery of mesenchymal stem cells (MSCs).

Young Sook Lee1, Kwang Suk Lim1, Jung-Eun Oh2, A-Rum Yoon2, Wan Seok Joo3, Hyun Soo Kim3, Chae-Ok Yun2, Sung Wan Kim4.   

Abstract

Multipotent mesenchymal stem cells (MSCs) promise a therapeutic alternative for many debilitating and incurable diseases. However, one of the major limitations for the therapeutic application of human MSC (hMSC) is the lengthy ex vivo expansion time for preparing a sufficient amount of cells due to the low engraftment rate after transplantation. To solve this conundrum, a porous biodegradable polymeric microsphere was investigated as a potential scaffold for the delivery of MSCs. The modified water/oil/water (W1/O/W2) double emulsion solvent evaporation method was used for the construction of porous microspheres. PEI1.8k was blended with poly(lactic-co-glycolic acid) (PLGA) to enhance electrostatic cellular attachment to the microspheres. The porous PLGA/PEI1.8k (PPP) particles demonstrated an average particle size of 290μm and an average pore size of 14.3μm, providing a micro-carrier for the MSC delivery. PPP particles allowed for better attachment of rMSCs than non-porous PLGA/PEI1.8k (NPP) particles and non-porous (NP) and porous PLGA (PP) microspheres. rMSC successfully grew on the PPP particles for 2weeks in vitro. Next, PPP particles loaded with 3 different amounts of hMSC showed increased in vivo engraftment rates and maintained the stemness characteristics of hMSC compared with hMSCs-alone group in rats 2weeks after intramyocardial administration. These customized PPP particles for MSC delivery are a biodegradable and injectable scaffold that can be used for clinical applications.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cell therapy; Human stem cell; Mesenchymal stem cell; PEI(1.8k); PLGA; Porous microparticle

Mesh:

Substances:

Year:  2015        PMID: 25575866      PMCID: PMC4395535          DOI: 10.1016/j.jconrel.2015.01.004

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  26 in total

Review 1.  Stem cell therapy in perspective.

Authors:  Bodo E Strauer; Ran Kornowski
Journal:  Circulation       Date:  2003-02-25       Impact factor: 29.690

2.  Water-soluble lipopolymer for gene delivery.

Authors:  R I Mahato; S W Kim
Journal:  Bioconjug Chem       Date:  2001 May-Jun       Impact factor: 4.774

3.  Editorial: Our top 10 developments in stem cell biology over the last 30 years.

Authors:  Lyle Armstrong; Majlinda Lako; Noel Buckley; Terry R J Lappin; Martin J Murphy; Jan A Nolta; Mark Pittenger; Miodrag Stojkovic
Journal:  Stem Cells       Date:  2012-01       Impact factor: 6.277

Review 4.  Polymeric scaffold aided stem cell therapeutics for cardiac muscle repair and regeneration.

Authors:  Rajesh Lakshmanan; Uma Maheswari Krishnan; Swaminathan Sethuraman
Journal:  Macromol Biosci       Date:  2013-08-25       Impact factor: 4.979

5.  Human erythropoietin gene delivery for cardiac remodeling of myocardial infarction in rats.

Authors:  Youngsook Lee; Arlo N McGinn; Curtis D Olsen; Kihoon Nam; Minhyung Lee; Sug Kyun Shin; Sung Wan Kim
Journal:  J Control Release       Date:  2013-06-25       Impact factor: 9.776

6.  Influence of PEI as a core modifying agent on PLGA microspheres of PGE₁, a pulmonary selective vasodilator.

Authors:  Vivek Gupta; Fakhrul Ahsan
Journal:  Int J Pharm       Date:  2011-04-16       Impact factor: 5.875

7.  Multilineage potential of adult human mesenchymal stem cells.

Authors:  M F Pittenger; A M Mackay; S C Beck; R K Jaiswal; R Douglas; J D Mosca; M A Moorman; D W Simonetti; S Craig; D R Marshak
Journal:  Science       Date:  1999-04-02       Impact factor: 47.728

8.  Delivering mesenchymal stem cells in collagen microsphere carriers to rabbit degenerative disc: reduced risk of osteophyte formation.

Authors:  Yuk Yin Li; Hua Jia Diao; Tze Kit Chik; Cin Ting Chow; Xiao Meng An; Victor Leung; Kenneth Man Chi Cheung; Barbara Pui Chan
Journal:  Tissue Eng Part A       Date:  2014-02-06       Impact factor: 3.845

Review 9.  Bone marrow stromal stem cells: nature, biology, and potential applications.

Authors:  P Bianco; M Riminucci; S Gronthos; P G Robey
Journal:  Stem Cells       Date:  2001       Impact factor: 6.277

10.  Epicardial placement of mesenchymal stromal cell-sheets for the treatment of ischemic cardiomyopathy; in vivo proof-of-concept study.

Authors:  Nobuko Tano; Takuya Narita; Masahiro Kaneko; Chiho Ikebe; Steven R Coppen; Niall G Campbell; Manabu Shiraishi; Yasunori Shintani; Ken Suzuki
Journal:  Mol Ther       Date:  2014-06-16       Impact factor: 11.454

View more
  5 in total

Review 1.  Nanostructured injectable cell microcarriers for tissue regeneration.

Authors:  Zhanpeng Zhang; Thomas W Eyster; Peter X Ma
Journal:  Nanomedicine (Lond)       Date:  2016-05-27       Impact factor: 5.307

2.  HGF and IGF-1 promote protective effects of allogeneic BMSC transplantation in rabbit model of acute myocardial infarction.

Authors:  Guang-Wei Zhang; Tian-Xiang Gu; Xiao-Yu Guan; Xue-Jun Sun; Xun Qi; Xue-Yuan Li; Xiao-Bing Wang; Feng Lv; Lei Yu; Da-Qing Jiang; Rui Tang
Journal:  Cell Prolif       Date:  2015-10-15       Impact factor: 6.831

3.  Human Mesenchymal Stem Cell Delivery System Modulates Ischemic Cardiac Remodeling With an Increase of Coronary Artery Blood Flow.

Authors:  Young Sook Lee; Wan Seok Joo; Hyun Soo Kim; Sung Wan Kim
Journal:  Mol Ther       Date:  2016-01-19       Impact factor: 11.454

4.  In vitro cell delivery by gelatin microspheres prepared in water-in-oil emulsion.

Authors:  Nicola Contessi Negrini; Maria Veronica Lipreri; Maria Cristina Tanzi; Silvia Farè
Journal:  J Mater Sci Mater Med       Date:  2020-02-14       Impact factor: 3.896

5.  Mineral particles modulate osteo-chondrogenic differentiation of embryonic stem cell aggregates.

Authors:  Yun Wang; Xiaohua Yu; Christopher Baker; William L Murphy; Todd C McDevitt
Journal:  Acta Biomater       Date:  2015-10-24       Impact factor: 8.947

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.